Overview
AVEC Pharma offers products from the SeptOral line, including SeptOral Halito, ortho, Med and Profilactic, as well as Sofargen Repair and Sofargen spray. The company states that it has 20 years of experience, uses high-quality raw materials, and tests its products for quality and purity.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2011-01-20. Active
42 1020 5226 0000 6502 0630 7666- 97 1020 5226 0000 6302 0378 7199
- 39 1020 5226 0000 6102 0499 5603
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
18 public aid cases recorded, with a total value of $59,517.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 14, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $4,862$4,862 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 15, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3,014$3,014 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 16, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,007$3,007 | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
Trademarks
AVEC Pharma holds 3 active trademarks registered with the Polish Patent Office. 4 marks have expired or were not registered. The first mark was filed in 2013.
| Mark | Protected until | |
|---|---|---|
| SeptOral | Jul 21, 2027 | |
| TRAN familijny ZDROWIE I ODPORNOŚĆ | Jul 19, 2033 | |
| Pharma Avec | Mar 15, 2033 | |
| PROBIOTYK + PREBIOTYK oxeo GG dietetyczny środek spożywczy specjalnego przeznaczenia medycznego | – | |
| Sedarel SPOKÓJ I RELAKS suplement diety | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, joint action by the First Vice-President of the Management Board with another member of the management board is required to make declarations of will and sign on behalf of the company in property and non-property matters.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Janina Zimoch (51) | 900 | $12,155.59 | 55.5556% |
Michał Krzysztof Zimoch (51) | 720 | $9,724.47 | 44.4444% |
Agnieszka Janina Zimoch and Michał Krzysztof Zimoch hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Profimedsp. z o.o. | $4,109,286.04 | profimed.com | ||
| Aqvitox Polskasp. z o.o. | $3,504,497.00 | aqvitox.pl | ||
| Activepharm Labssp. z o.o. | $2,922,149.92 | activepharm.com.pl | ||
| Steriwundsp. z o.o. | $2,832,891.51 | steriwund.pl | ||
| Neoset Profisp. z o.o. | $2,502,244.52 | neoset.com.pl | ||
| Eumedsp. z o.o. | $2,086,044.24 | eumed.pl | ||
| Citipharmsp. z o.o. + limited partnership | $1,829,937.74 | citipharm.pl | ||
| Equadentsp. z o.o. | $1,636,062.40 | equadent.pl | ||
| Aprodsp. z o.o. | $994,275.26 | aprod.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-11-02 | PKD change (Removed: 18.13.Z, 20.42.Z, 21.10.Z, 21.20.Z, 46.12.Z, 46.14.Z, 46.17.Z, 46.18.Z, 46.19.Z, 46.33.Z, 46.34.A, 46.34.B, 46.37.Z, 46.39.Z, 46.49.Z, 46.75.Z, 46.76.Z, 47.11.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 47.99.Z, 52.10.B, 52.21.Z, 52.24.C, 58.11.Z, 58.12.Z, 58.13.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.12.Z, 63.91.Z, 63.99.Z, 68.10.Z, 68.20.Z, 68.31.Z, 68.32.Z, 69.20.Z, 70.21.Z, 70.22.Z, 72.11.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 78.10.Z, 78.20.Z, 78.30.Z, 82.11.Z, 82.19.Z, 82.99.Z, 85.60.Z, 86.90.E; Added: 77.11.Z) | |
| 2011-04-21 | Share capital change (6,000.00 PLN → 81,000.00 PLN) | |
| 2010-11-12 | Entered in the register |
FAQ
Last updated: 2026-06-19